Log In
Print
BCIQ
Print
Print this Print this
 

Decuprate (WTX101) (formerly ATN-224)

  Manage Alerts
Collapse Summary General Information
Company Wilson Therapeutics AB
DescriptionSecond-generation analog of ammonium tetrathiomolybdate
Molecular Target Superoxide dismutase 1 (SOD1)
Mechanism of ActionSuperoxide dismutase (SOD1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationWilson's disease
Indication DetailsTreat Wilson's disease
Regulatory Designation

U.S. - Orphan Drug (Treat Wilson's disease);
EU - Orphan Drug (Treat Wilson's disease)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today